Aims and scope
Aims and scope
Antimicrobial Resistance and Infection Control believes that future solutions require a better understanding of the factors contributing to the development and spread of multi-drug resistance pathogens, interventions to prevent transmission and infection, and insight into the difference between settings with limited, middle or high resources.
Antimicrobial Resistance and Infection Control combines best practices, experience and latest research results from around the globe to overcome the challenge posed by healthcare-associated infections. The journal welcomes manuscripts related to the epidemiology, surveillance, and prevention of healthcare infections and antimicrobial resistance.
The journal’s primary focus is on healthcare settings, but also considers community-based public health research relating to the prevention of antimicrobial resistance.
Manuscripts on the following are in scope:
• Prevention of healthcare-associated infection
• Infection control and antimicrobial resistance in high-risk settings (e.g. ICUs)
• Healthcare-associated infection prevention and antimicrobial resistance in special settings e.g. long-term care facilities
• Infection control and antimicrobial resistance in community and public healthcare settings
• Special considerations in infection control and antimicrobial resistance in resource-limited settings
• Antimicrobial stewardship interventions are within scope where they seek to reduce antimicrobial resistance or healthcare infections
• Surveillance of healthcare-associated infections and antimicrobial-resistant infections in healthcare and the community
Manuscripts on the following are not in scope:
• Single-point and single-center estimates of antimicrobial resistance rates, unless they illustrate new developments
• Antimicrobial resistance in animals or the environment, unless there are clear links to human health (One Health Principle)
• Studies focusing on the clinical diagnosis or treatment of infectious diseases
• Laboratory-based research and microbiological aspects of AMR without implications for clinical infection prevention